TY - JOUR
T1 - Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans
AU - Logue, Mark W.
AU - Schu, Matthew
AU - Vardarajan, Badri N.
AU - Farrell, John
AU - Bennett, David A.
AU - Buxbaum, Joseph D.
AU - Byrd, Goldie S.
AU - Ertekin-Taner, Nilufer
AU - Evans, Denis
AU - Foroud, Tatiana
AU - Goate, Alison
AU - Graff-Radford, Neill R.
AU - Kamboh, M. Ilyas
AU - Kukull, Walter A.
AU - Manly, Jennifer J.
AU - Hainesm, Jonathan L.
AU - Mayeuxl, Richard
AU - Pericak-Vancen, Margaret A.
AU - Schellenbergo, Gerard D.
AU - Lunettab, Kathryn L.
AU - Baldwina, Clinton T.
AU - Daniele Fallinp, M.
AU - Farrer, Lindsay A.
N1 - Publisher Copyright:
© 2014 The Alzheimer's Association. All rights reserved.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Background Less is known about the genetic basis of Alzheimer's disease (AD) in African Americans (AAs) than in non-Hispanic whites. Methods Whole exome sequencing (WES) was performed on seven AA AD cases. Disease association with potentially AD-related variants from WES was assessed in an AA discovery cohort of 422 cases and 394 controls. Replication was sought in an AA sample of 1037 cases and 1869 controls from the Alzheimer Disease Genetics Consortium (ADGC). Results Forty-four single nucleotide polymorphisms (SNPs) from WES passed filtering criteria and were successfully genotyped. Nominally significant (P <.05) association to AD was observed with two African-descent specific AKAP9 SNPs in tight linkage disequilibrium: rs144662445 (P =.014) and rs149979685 (P =.037). These associations were replicated in the ADGC sample (rs144662445: P =.0022, odds ratio [OR] = 2.75; rs149979685: P =.0022, OR = 3.61). Conclusions Because AKAP9 was not previously linked to AD risk, this study indicates a potential new disease mechanism.
AB - Background Less is known about the genetic basis of Alzheimer's disease (AD) in African Americans (AAs) than in non-Hispanic whites. Methods Whole exome sequencing (WES) was performed on seven AA AD cases. Disease association with potentially AD-related variants from WES was assessed in an AA discovery cohort of 422 cases and 394 controls. Replication was sought in an AA sample of 1037 cases and 1869 controls from the Alzheimer Disease Genetics Consortium (ADGC). Results Forty-four single nucleotide polymorphisms (SNPs) from WES passed filtering criteria and were successfully genotyped. Nominally significant (P <.05) association to AD was observed with two African-descent specific AKAP9 SNPs in tight linkage disequilibrium: rs144662445 (P =.014) and rs149979685 (P =.037). These associations were replicated in the ADGC sample (rs144662445: P =.0022, odds ratio [OR] = 2.75; rs149979685: P =.0022, OR = 3.61). Conclusions Because AKAP9 was not previously linked to AD risk, this study indicates a potential new disease mechanism.
KW - AKAP9
KW - African American
KW - Genetic association
KW - Late-onset Alzheimer's disease
KW - Rare variant
KW - Whole-exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=84927158295&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927158295&partnerID=8YFLogxK
U2 - 10.1016/j.jalz.2014.06.010
DO - 10.1016/j.jalz.2014.06.010
M3 - Article
C2 - 25172201
AN - SCOPUS:84927158295
SN - 1552-5260
VL - 10
SP - 609-618.e11
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 6
ER -